Clinical trial

Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin…

NCT00003611 · Alliance for Clinical Trials in Oncology, Other · Completed

Key facts

NCT number NCT00003611
Title Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation
Official title Chemoprevention Trial of Acitretin Versus Placebo in Solid Organ Transplant Recipients With Multiple Prior Treated Skin Cancers
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Study type Interventional
Conditions Non-melanomatous Skin Cancer
Intervention type Drug, Other
Interventions acitretin, placebo
Enrollment 129
Start date May 1, 2000
Primary completion Feb 1, 2003
Completion Jun 1, 2003
First posted Jan 27, 2003
Last update posted Jul 13, 2016
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies